Pancreatic Cancer Research

ResearcherOregon Health & Science UniversityActive in the last 2 years

Jungsun Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2454-8065. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
22
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: 2 papers

Papers 10

  1. Protocol to purify and culture human pancreatic cancer cells from patient-derived xenografts. Last author DOI 10.1016/j.xpro.2025.103672↗
  2. Long Noncoding RNAs Preserve Pancreatic Cancer Identity and Resist Cell Fate Conversion Last author DOI 10.1101/2025.06.25.661419↗
  3. Sendai virus is robust and consistent in delivering genes into human pancreatic cancer cells. Last author DOI 10.1016/j.heliyon.2024.e27221↗
  4. Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency. Co-author DOI 10.3791/65811↗
  5. Cell Dissemination in Pancreatic Cancer. Co-author DOI 10.3390/cells11223683↗
  6. Longitudinal Analysis of Human Pancreatic Adenocarcinoma Development Reveals Transient Gene Expression Signatures. Co-author DOI 10.1158/1541-7786.mcr-21-0483↗
  7. THBS2/CA19-9 Detecting Pancreatic Ductal Adenocarcinoma at Diagnosis Underperforms in Prediagnostic Detection: Implications for Biomarker Advancement. Co-author DOI 10.1158/1940-6207.capr-20-0403↗
  8. Generation of Induced Pluripotent Stem Cell-Like Lines from Human Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1007/978-1-4939-8879-2_4↗
  9. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Co-author DOI 10.1126/scitranslmed.aah5583↗
  10. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Co-author DOI 10.1016/j.celrep.2013.05.036↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dmytro Grygoryev · 5 shared papers, 2021–2025 · strength 0.98
  2. Brett C. Sheppard · 4 shared papers, 2024–2025 · strength 0.84
  3. Rosalie C. Sears · 4 shared papers, 2024–2025 · strength 0.84
  4. Terry K. Morgan · 4 shared papers, 2021–2025 · strength 0.74
  5. Jason M. Link · 3 shared papers, 2024–2025 · strength 0.60
  6. Kenneth Zaret · 5 shared papers, 2013–2021 · strength 0.56
  7. Amani Alshaikh · 2 shared papers, 2024 · strength 0.44
  8. Abdenour Soufi · 2 shared papers, 2024 · strength 0.44
  9. Brittany L. Allen-Petersen · 2 shared papers, 2024–2025 · strength 0.41
  10. Julien Tessier · 2 shared papers, 2025 · strength 0.41
  11. Ann L. Oberg · 2 shared papers, 2017–2021 · strength 0.20
  12. Gloria M. Petersen · 2 shared papers, 2017–2021 · strength 0.20
  13. Thuy T. M. Ngo · 1 shared paper, 2021 · strength 0.13
  14. Shirsa Udgata · 1 shared paper, 2021 · strength 0.13
  15. Erica L. Carpenter · 1 shared paper, 2021 · strength 0.13
  16. Kari G. Rabe · 1 shared paper, 2017 · strength 0.07
  17. Suresh T. Chari · 1 shared paper, 2017 · strength 0.07
  18. John Parker Hoffman · 1 shared paper, 2013 · strength 0.03
  19. Andrew A. Gumbs · 1 shared paper, 2013 · strength 0.03
  20. Maximilian Reichert · 1 shared paper, 2013 · strength 0.03
  21. Ben Z. Stanger · 1 shared paper, 2013 · strength 0.03
  22. Andrew D. Rhim · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.